The Sonic Healthcare Ltd share price has fallen by more than 18% since 19 August 2026, which is a drop for an ASX healthcare share in a short time.
Sonic Healthcare is a global pathology business with a presence across some countries, including Australia, Germany, the US, the UK, Switzerland, and New Zealand.
In FY26, revenue rose 13% to $10.9 billion, underlying operating profit grew 11% to $1.9 billion, operating profit rose 9% to $1.88 billion, underlying net profit rose 17% to $621 million, and statutory net profit grew 18% to $608 million.
Assuming the same exchange rate as FY26, EBITDA is predicted to grow to between $1.95 billion and $2.03 billion, excluding back office IT systems transformation costs of around A$30 million.
4 sentences from our version of the report,
chosen to cover it. Nothing here is written; every line is in the article below.
How
Summarized version
The Sonic Healthcare Ltd share price has fallen by more than 18% since 19 August 2026, which is a drop for an ASX healthcare share in a short time.
The report’s most important sentence, shortened and in plain words. How
Headline check
All three things this headline claims are in the report.
Figures, names and quoted words in the headline, looked for in the report itself — not in the summary above. How this is checked
library pictureNot from this story. A library photograph of
stock market trading screens, used to illustrate it.
RStar 40' x 60' Showbooth by Phil Manker
Phil Manker / flickr, CC BY
The article, shortened and in plain language
The Sonic Healthcare Ltd share price has fallen by more than 18% since 19 August 2026, which is a drop for an ASX healthcare share in a short time. When businesses fall that much, it's worthwhile considering an investment.
Sonic Healthcare is a global pathology business with a presence across some countries, including Australia, Germany, the US, the UK, Switzerland, and New Zealand.
Let's take a look at whether this is a good time to buy or not.
Healthcare is one of those industries that have defensive earnings.
In FY26, revenue rose 13% to $10.9 billion, underlying operating profit grew 11% to $1.9 billion, operating profit rose 9% to $1.88 billion, underlying net profit rose 17% to $621 million, and statutory net profit grew 18% to $608 million.
Statutory earnings per share grew 15% to $1.23.
Assuming the same exchange rate as FY26, EBITDA is predicted to grow to between $1.95 billion and $2.03 billion, excluding back office IT systems transformation costs of around A$30 million.
Sonic Healthcare has a history of dividends.
The Sonic Healthcare share price is trading on a price-earnings ratio of less than 16.
Shortened to 1 minute
of reading, this version reads 12.4 on the Niral Score.
You are reading our version, not theirs.
This is The Motley Fool Australia's report shortened to its most important sentences, in plainer words, with
verdicts and loaded words taken out. Plain description stays, and so do adjectives
that carry a fact, such as "former" or "federal". The reporting, the facts and the quotations
are theirs — quotations are never edited — and the indicators beside it measure
this version. Hover or tap Adjectives to see every one left in the text.
How this outlet filed it, and how we rewrote it
No other newsroom we read has filed on this event, so there is nothing to compare it with yet.
Readers can ask a question about this story here.
Questions and answers are for subscribers.
Sign in
to read them.
Comments are read before they appear where anything in them needs a person to look.
Nothing posted here is ever deleted; a comment taken down keeps its text and the reason,
so the decision can be looked at again. How this works
